This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Innovative Strategies to Improve Outcomes in Major Depression

Innovative Strategies to Improve Outcomes in Major Depression

Format

Webcast

Time to Complete

1 hour

Released

September 9, 2019

Expires

September 9, 2020
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditsTM
1.00 / CNE Contact Hours (0.60 pharmacotherapy credit)

Accredited Provider

Jointly provided by Postgraduate Institute for Medicine (PIM) and Global Medical Education

Commercial Supporter

This activity is supported by an independent educational grant from Allergan.

Program Description

Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study demonstrated the need for alternate medications for patients who do not benefit from standard antidepressants. Innovative strategies that target novel mechanisms like ketamine, esketamine, rapastinel, brexanolone and SAGE-217 may fill some of the unmet needs.

Intended Audience

This activity is intended for physicians, physician assistants, nurse practitioners and registered nurses engaged in the care of patients with major depression.

Educational Objectives

Upon completion of the activity, participants should be better able to:

  • Treat major depression within 2 weeks.
  • Use evidence-based treatments to achieve remission in major depression.
  • Discuss novel targets including glutamate for treating major depression.
  • Utilize treatments with innovative mechanisms to treat major depression.

Conflict Of Interest Disclosure Policy

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty

Michael Thase, M.D.
Professor of Psychiatry, Perelman School of Medicine
University of Pennsylvania

Dr. Thase discloses the following:
Consulting Fees: Acadia, Akili, Alkermes, Allergan, Cerecor, Fabre-Kramer, Gerson Lehrman
Group, Guidepoint Global, Johnson & Johnson, Moksha8, Nestlé, Neuralstrim, Novartis, Otsuka,
Pfizer, Sunovion
Contracted Research: Acadia, Agency for Healthcare Research and Quality (AHRQ), Alkermes,
Allergan, AssureRX Health, Avanir, Axome, Intracellular, Johnson & Johnson, National Institutes
of Health / National Institute of Mental Health (NIMH), Otsuka, Patient-Centered Outcomes
Research Institute (PCORI), Takeda
Royalties: American Psychiatric Foundation, Guilford Publications, Herald House, W.W.
Norton & Company
Spouse: Peloton Advantage

Accredited Provider Disclosure

The PIM planners and managers have nothing to disclose.

Publishing Staff Disclosures

The Global Medical Education planner and manager, Prakash Masand, MD, has disclosed the following:
Consulting Fees: Allergan, Lundbeck, Sunovion, Takeda
Speakers’ Bureau: Allergan, Lundbeck, Sunovion, Takeda
Contracted Research: Allergan

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Medical Education. Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statement

The Postgraduate Institute for Medicine designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.00

Type

CNE Contact Hour(s)

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Medical Education. Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statement

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.00 contact hour.

Designated for 0.60 contact hours of pharmacotherapy credit for Advance Practice Registered Nurses.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Instructions

To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/Exam History, which you can access at any time.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue